Connect with us

Technology

Carbon Nanotubes Market Set to Surge at 20.6% CAGR Through 2029, Driven by Emerging Technologies and Global Demand

Published

2 years ago

on

BCC Research analyst states that carbon nanotubes are transforming industries with their superior strength, conductivity, and thermal stability

BOSTON, Nov. 27, 2024 /PRNewswire/ — Boston: “According to the latest study from BCC Research “Global Markets and Technologies for Carbon Nanotubes,” demand for these products is projected to grow from $2.3 billion in 2024 to $5.9 billion by 2029, at a compound annual growth rate (CAGR) of 20.6% from 2024 through 2029.”

In this report, the global market for carbon nanotubes is analyzed, focusing on single-walled and multi-walled types. Technologies such as chemical vapor deposition and arc discharge as well as high-pressure carbon monoxide and laser ablation are examined, including their use in the transportation, energy storage, electronics, semiconductors, chemicals, materials, polymers, and medical applications industries. Regional analysis covers North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. With a base year of 2023 and forecasts through 2029, the market size estimates reflect revenues generated by companies using industrial-scale carbon nanotube technologies.

As renewable energy is increasingly integrated into global systems, carbon nanotubes offer significant advantages in energy storage and conversion, particularly by enhancing lithium-ion batteries with improved conductivity and structural integrity, ensuring greater resilience during charge/discharge cycles. In healthcare, the rising need for smart drug delivery, particularly in North America and Europe, positions carbon nanotubes as effective drug vectors that target specific body areas while minimizing interaction with healthy tissues. Additionally, carbon nanotubes are increasingly being used in the design and fabrication of smaller, high-performance consumer electronics, such as smartphones, transistors and wearable devices.

Please click here for more details on the report on the global market for carbon nanotubes.

The factors driving the global market for carbon nanotubes include:

Advances in the Medical Sector: Carbon nanotubes are enhancing drug delivery by targeting specific cells, improving treatment effectiveness, and reducing side effects. They are also integrated into biosensors for early disease detection and are used in cancer treatment to target and destroy cancer cells precisely, minimizing damage to healthy tissues.

Demand in Electronics and Semiconductors: Carbon nanotubes are increasingly being integrated into transistors, potentially surpassing silicon in speed and efficiency, and are used in sensors to enhance performance in advanced electronics.

Integration in Energy Storage and Conversion: Carbon nanotubes improve energy density and extend the life of lithium-ion batteries, enhance the efficiency of fuel cells, and increase the effectiveness of solar cells in converting sunlight to electricity.

Use in EVs: The EV industry uses carbon nanotubes to develop lightweight, strong materials for better energy efficiency. They also enhance EV battery performance, leading to longer ranges and quicker charging, and are used in conductive composites to improve vehicle safety and functionality.

Request a sample copy of the global market for carbon nanotubes report.

Report Synopsis

Report Metric

Details

Base year considered

2023

Forecast period considered

2024-2029

Base year market size

$2.0 billion

Market size forecast  

$5.9 billion

Growth rate    

CAGR of 20.6% from 2024 to 2029

Segments covered

Type, Technology, End User, and Region

Regions covered

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA)

Countries covered

U.S., Canada, Mexico, Brazil, Argentina, Chile, China, Japan, India, South Korea, Germany, U.K., France, Italy, Spain, Saudi Arabia, UAE and South Africa

Market drivers

•  Advances in the medical sector

•  Increasing use in the electronics and semiconductors industry

•  Integration of carbon nanotubes in energy storage and conversion

•  Growing use in EVs

 

Interesting facts about the global market for carbon nanotubes:

 •  Carbon nanotubes have transformed the pharmaceutical industry with their ability to penetrate cell membranes, making them ideal for targeted drug delivery.

•  Carbon nanotubes may replace silicon in electronics due to superior conductivity, enhancing silicon anodes in Li-ion batteries for longer cycles.

•  Carbon nanotubes are key in developing smart textiles with electrical conductivity, flame retardance, and durability, paving the way for wearable electronics and heated garments.

•  Carbon nanotube manufacturers are exploring eco-friendly production methods using bioethanol and plant-based oils to align with sustainability goals.

The report addresses the following questions:

1.  What are the projections for the market?

•  The global market for carbon nanotubes is projected to grow from $2.0 billion in 2023 to $5.9 billion in 2029 at a compound annual growth rate (CAGR) of 20.6% during the forecast period.

2.  Which factors are driving the growth of the market?

•  These factors include:

o  Advances in the medical sector.

o  Demand from the electronics and semiconductors industry.

o  Integration of Carbon nanotubes in energy storage and conversion systems.

o  Use in EVs.

3.  Which market segments are covered in the report?

•  The global market for carbon nanotubes is segmented by type, technology, end-user and region. Types, include single and multi-walled carbon nanotubes. Technologies include chemical vapor deposition, arc discharge, high-pressure carbon monoxide, laser ablation and others (electrolysis, ball milling, diffusion flame synthesis, etc.). End users include the transportation, energy and storage, electronics and semiconductors, chemicals, materials, polymers, medical, sports equipment, construction and textile sectors. Regions covered are North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.

4.  Which technology segment will dominate the market by the end of 2029?

•  The chemical vapor deposition segment, which is one of the most widely used and versatile methods for synthesizing Carbon nanotubes, will maintain its dominance through 2029. It relies on the thermal decomposition of a carbon-containing gas, which deposits carbon atoms on a catalyst surface. Recent advances in the catalyst design have significantly improved the quality, scalability, and control over the growth process for carbon nanotube synthesis.

5.  Which region has the largest share of the global market?

•  Asia-Pacific’s largest market share is driven by a combination of economic factors, industrial applications, and a focus on innovation and sustainability. Rising demand for renewable energy, use of EVs, and supportive government initiatives will increase the potential market for carbon nanotubes.

Leading companies in the market include:

•  Anp Corp.

•  Arkema

•  Birla Carbon

•  Cabot Corp.

•  Canatu

•  Chasm

•  Jiangsu Cnano Technology Co. Ltd.

•  Kumho Petrochemical

•  Lg Chem

•  Nano-C

•  Nanografi Nano Technology

•  Novarials Corp.

•  Ocsial

•  Raymor Industries Inc.

•  Thomas Swan & Co. Ltd.

More Related Reports:

Global Markets and Technologies for Nanofibers: This report provides an analysis of the global market for nanofiber technologies, with forecasts through 2028. It covers key material types—polymers, hybrids, synthetics, naturals, carbons, metals, alloys, ceramics, glasses, composites, and semiconductors—and their applications in the life sciences, energy, electronics, consumer goods and transportation sectors. The study also offers regional market breakdowns for North America, Europe, Asia-Pacific, and the Rest of the World, focusing on commercially viable nanofiber materials and applications expected to be significant by 2028.

 

Nanomaterials in Personalized Medicine: Global Markets: This report provides an analysis of nanomaterials in the personalized medicine market, with estimates for 2023 and projections through 2028. It highlights the current and future market, assesses the competitive landscape, and explores regulatory scenarios and market drivers, restraints and opportunities. The study segments the market by product type—including proteins, monoclonal antibodies, nanocrystals, liposomes, gold nanoparticles, and quantum dots—and by the regions of North America, Europe, Asia-Pacific, and the Rest of the World, with insights into key markets of the U.S., Germany, the U.K., Italy, France, Japan, China, and India.

Directly purchase a copy of the report from BCC Research.

For further information or to make a purchase, please get in touch with info@bccresearch.com.

About BCC Research

BCC Research market reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts’ goal is to help readers make informed business decisions, free of noise and hype.

Contact Us

Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/carbon-nanotubes-market-set-to-surge-at-20-6-cagr-through-2029–driven-by-emerging-technologies-and-global-demand-302317807.html

Related Topics:
Continue Reading

Technology

Epson to Showcase Collaborative 6-Axis Robot and Integrated Automation Solutions at The ASSEMBLY Show 2026

Published

51 minutes ago

on

October 21, 2026

By

AX6 Cobot and Live Demonstrations Highlight Epson’s Expanding Automation Portfolio

LOS ALAMITOS, Calif., Oct. 21, 2026 /PRNewswire/ — Epson Robots, the #1 SCARA robot manufacturer in the world, will showcase its expanding automation portfolio, including its first collaborative robot, the AX6, at The ASSEMBLY Show 2026, taking place in Rosemont, Illinois from Oct. 27-29, 2026, in booth #331.

Epson to Showcase AX6 Cobot and Integrated Automation Solutions with Live Demos at The ASSEMBLY Show 2026

“Every automation application has different safety requirements, and there is no one-size-fits-all approach,” said Scott Marsic, group product manager, Epson Robots. “With the AX6 and SafeSenseTM technology, Epson is giving manufacturers more options to select the right solution for their requirements. At The ASSEMBLY Show, we look forward to demonstrating how these offerings complement our broader robotics portfolio and help manufacturers address a wide range of automation needs.”

With Epson’s latest automation technologies, attendees can experience live demonstrations showcasing integrated robotics, vision, and feeding solutions. The live applications will highlight practical, cost-effective solutions for real-world production environments. An educational speaking session will also focus on selecting the right automation approach for each application. Epson highlights at The ASSEMBLY Show 2026 will include:

Speaking Engagement”Automation Isn’t the Answer. Choosing the Right Automation Is.” – Marsic will outline a practical framework for choosing the right automation strategy, from evaluating opportunities and avoiding application creep to balancing critical design considerations such as safety, robot geometry, workcell design and flexibility. The session will focus on solving the right business problem to create automation systems that are easier to implement, scale and maintain while delivering stronger productivity, reliability and long-term ROI. The session will take place Wednesday, October 28 from 2 – 2:30 p.m. at the Learning Theater.AX6 Collaborative 6-Axis Robot – See Epson’s first collaborative robot in action, featuring a lightweight, compact footprint and intuitive no-code software designed to simplify programming and deployment. Power- and force-limiting capabilities and flexible end-of-arm options support collaborative applications where space, ease of use and fast redeployment are priorities.SafeSense Interactive Demo – Experience a hands-on demonstration of Epson’s SafeSense technology, which uses sensors to detect when a person enters the robot’s workspace, supporting safe human-robot interaction while maintaining high-performance automation.IntelliFlexTM Feeding System – See live demonstrations featuring Epson’s latest SCARA and 6-Axis robots integrated with IntelliFlex Feeding Systems for automated part handling and assembly applications.Epson RC+® Development Software – Explore Epson’s PC-based environment with intuitive GUI Builder for custom interfaces along with integrated vision and IntelliFlex capabilities. Developed and supported by Epson, the software is designed to simplify automation development and deployment.

The ASSEMBLY Show 2026 will take place on Oct. 27 from 4 p.m. to 7 p.m. CDT, Oct. 28 from 10 a.m. to 5 p.m. CDT and Oct. 29 from 9 a.m. to 2 p.m. CDT at the Donald E. Stephens Convention Center in Rosemont, Illinois. To learn more about Epson robot solutions at the show, stop by booth #331 or visit www.epsonrobots.com to contact a robot expert.

About Epson Robots

Epson Robots is a global leader in PC-controlled precision factory automation, with well over 250,000 units sold worldwide1 and a product line of hundreds of models of easy-to-use SCARA and 6-Axis robots based on a common PC-based platform. Building on four decades of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For more information, visit www.epsonrobots.com.

About Epson

Epson is a technology innovation and engineering company whose philosophy of efficient, compact and precise innovation enriches lives and helps create a better world. The company uses technology and engineering ability to implement real-world solutions in precision innovation, industrial and robotics, office and home printing, and visual and lifestyle.

Led by the Japan-based Seiko Epson Corporation, the worldwide Epson Group generates annual sales of more than JPY 1.4 trillion. corporate.epson/en/

Epson America, Inc., based in Los Alamitos, Calif., is Epson’s regional headquarters for the U.S., Canada and Latin America. To learn more about Epson, please visit: epson.com. You may also connect with Epson America on Facebook (facebook.com/Epson), X (x.com/EpsonAmerica), YouTube (youtube.com/epsonamerica) and Instagram (instagram.com/EpsonAmerica).

1 Epson internal sales data through April 2026.

EPSON and Epson RC+ are registered trademarks of Seiko Epson Corporation. SafeSense and IntelliFlex are trademarks of Epson America, Inc. All other product and brand names are trademarks and/or registered trademarks of their respective companies. Epson disclaims any and all rights in these marks. Copyright 2026 Epson America, Inc.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/epson-to-showcase-collaborative-6-axis-robot-and-integrated-automation-solutions-at-the-assembly-show-2026-302915812.html

SOURCE Epson America, Inc.

Continue Reading

Technology

Limber Health Launches Recovery Forecast, the First-Ever Predicted Outcomes Solution for Rehab Therapy

Published

51 minutes ago

on

October 21, 2026

By

Built on the largest risk-adjusted patient outcomes database in rehab therapy, Limber’s Recovery Forecast replaces traditional single point-in-time forecasts or MCID comparisons with a 90-day outlook

PITTSBURGH, Oct. 21, 2026 /PRNewswire/ — Limber Health, a Net Health company, today announced Recovery Forecast, the first-ever predicted outcomes trajectory solution for rehab therapy. Built into the Limber outcomes platform, Recovery Forecast maps each patient’s expected path throughout care by comparing them with millions of completed assessments and applying robust risk adjustment. Available to clients this fall, this new clinical capability covers the primary MSK regions of injury.

“Current solutions show a point-in-time measurement, but rarely provide context or insight into the score,” said Nirav Modi, president of Limber Health. “Recovery Forecast shows clinicians how a patient is progressing through their plan of care, so they can assess, adjust, and guide them toward the best possible improvement.”

Because Limber Outcomes follows patients from evaluation through the full episode of care, the expected path stays visible between visits. At intake, the feature predicts each patient’s path; then at each reassessment, clinicians compare the actual score with the prediction for real-time context. This gives clinicians an opportunity to adjust the course of care.

“Being able to predict a patient’s outcome trajectory is a game changer,” said Brian Kelly, Vice President of Innovation & Clinical Excellence at Ivy Health. “It transforms outcomes data into real-time clinical intelligence that enhances patient engagement, empowers proactive clinical decision-making, and ensures every patient is positioned for an optimal recovery.”

A newly developed progression indicator, the Predicted Moderate Clinical Improvement (P-MCI), marks where a patient is expected to reach clinically meaningful improvement. P-MCI is already part of commercial payer quality programs. It underpins five functional improvement measures in the CMS proposed rule for the 2027 Physician Fee Schedule, with Limber Health and Patient360 as measure stewards. For more information about Limber Recovery Forecast, click here. 

About Limber Health

Limber Health, a Net Health company, extends in-person musculoskeletal (MSK) care into the home with Remote Therapeutic Monitoring (RTM), Home Exercise Programs (HEP), and Limber Outcomes, which helps practices measure patient progress and predict recovery using the largest risk-adjusted patient outcomes database in rehab therapy. Limber’s solutions are developed by physical therapists and physicians. Learn more at www.limberhealth.com.

About Net Health

For over 30 years, Net Health has gathered specialty knowledge shaped by human expertise and informed by patient outcomes. Today, this depth of knowledge is the foundation for an AI-native specialty platform that delivers intelligence to clinicians across the care continuum, enabling them to be present with patients during the moments that matter. Net Health is a trusted source of specialty solutions for more than 34,000 healthcare organizations, and is a portfolio company of The Carlyle Group, Level Equity, and Silversmith Capital Partners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/limber-health-launches-recovery-forecast-the-first-ever-predicted-outcomes-solution-for-rehab-therapy-302915819.html

SOURCE Net Health Systems, Inc.

Continue Reading

Technology

Asuri.ai Launches Multi-Agent AI Platform for Persistent Business Workflows

Published

51 minutes ago

on

October 21, 2026

By

The agentic platform helps nontechnical teams save time, eliminate redundant work and deploy specialized AI agents across more than 1,000 existing applications

IRVINE, Calif., Oct. 21, 2026 /PRNewswire/ — Asuri today announced the launch of its multi-agent enterprise AI platform, designed to help businesses move beyond copilots and deploy persistent AI workflows across complete business processes.

As AI models become more capable, the challenge for businesses is shifting from generating answers to safely giving AI the context, system access and autonomy required to perform real work.

Asuri brings those pieces into one platform.

Nontechnical teams can define a business process, connect the applications involved, assign specialized agents to different responsibilities, and control what each agent can access, recommend or execute. By coordinating work that would otherwise require employees to repeatedly move between systems, gather information and perform routine follow-ups, Asuri helps organizations save time and remove redundant manual work.

“The model itself is becoming less of the bottleneck,” said Artem Bespaloff, CEO and co-founder of Asuri. “The harder problem is coordinating agents across real business systems while giving each one the right context, permissions and level of autonomy.”

Unlike traditional AI assistants that primarily respond to prompts, Asuri is designed around persistent multi-agent workflows.

Asuri combines multi-agent orchestration, workflow logic, persistent context and agent-level permission controls in a single environment, with more than 1,000 integrations connecting agents to the software businesses already use.

This allows companies to automate processes across existing systems instead of replacing their technology stack, reducing repetitive administrative work and freeing employees to focus on higher-value decisions and relationships.

As part of its launch, Asuri is introducing prebuilt customer intelligence workflows that consolidate information from multiple business systems, analyze client activity against company-defined rules, and automatically alert employees to significant developments. By eliminating the need to manually track client activity across different platforms, these workflows reduce the workload on sales and research teams, helping them stay informed, identify opportunities, and focus on higher-value activities.

The same architecture can support workflows across sales, operations, finance, customer success, research and internal compliance.

Businesses can learn more and request access at Asuri.ai.

About Asuri

Asuri is a multi-agent enterprise AI platform, built by Sprouter Technologies, for persistent, governed business workflows. With more than 1,000 integrations, Asuri helps organizations connect specialized AI agents across their existing applications, reduce repetitive work, save employee time and automate processes while maintaining individual permissions, autonomy boundaries and human oversight.

For more information you can contact team@asuri.ai

View original content to download multimedia:https://www.prnewswire.com/news-releases/asuriai-launches-multi-agent-ai-platform-for-persistent-business-workflows-302915829.html

SOURCE Sprouter Technologies

Continue Reading

Trending